Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study

Mod Rheumatol. 2023 Nov 1;33(6):1154-1161. doi: 10.1093/mr/roac132.

Abstract

Objectives: This study aimed to clarify mortality trends and their related factors in immunoglobulin G4-related disease (IgG4-RD) with various organ involvement.

Methods: We retrospectively reviewed the medical records of patients with IgG4-RD at a single rheumatology centre in Japan. We calculated the standardized mortality ratio using Japanese national mortality statistics. Cox regression analyses were also performed to assess mortality-related factors.

Results: A total of 179 patients with IgG4-RD were included with a median follow-up period of 47 months. The standardized mortality ratio in our cohort was 0.86 (95% confidence interval 0.41-1.59). Univariate Cox regression analyses indicated that the number of affected organs at diagnosis (hazard ratio 1.45, 95% confidence interval 1.02-2.05), estimated glomerular infiltration rate <45 ml/min/1.73 m2 at diagnosis (vs. ≥45, hazard ratio 8.48, 95% confidence interval 2.42-29.79), and the presence of malignancy during the clinical course (hazard ratio 5.85, 95% confidence interval 1.62-21.15) had a significant impact on the time to death.

Conclusions: Our findings suggest that in the rheumatology department, IgG4-RD does not significantly affect long-term patient survival. However, multi-organ involvement, renal dysfunction, and malignancy may be associated with higher mortality trends in IgG4-RD. Early detection and appropriate management of risk factors may improve the long-term prognosis of patients with IgG4-RD.

Keywords: IgG4-related disease; malignancy; mortality; standardized mortality ratio.

MeSH terms

  • East Asian People
  • Humans
  • Immunoglobulin G4-Related Disease*
  • Mortality / trends
  • Neoplasms / diagnosis
  • Retrospective Studies
  • Risk Factors